Cougar seeks to in-license drugs that are at an early stage in their clinical development. The Company typically requires its in-licensing candidates to have, at minimum, completed some initial clinical investigations (Phase I trial, physician sponsored IND) before Cougar will consider licensing the drug.
To submit a licensing opportunity to Cougar, please fill out the form below:
Cougar Biotechnology Licensing Submission
CONTACT INFORMATION
First Name
Last Name
Email Address
Telephone Number
Fax
Company/Institution Name
Company/Institution Street Address
Company/Institution City, State
Company/Institution Zip Code
What is the nature of the opportunity you are offering?
What is the drug's code name/trade name?
What is the mechanism of action of the drug?
Indication(s) proposed for the compound?
Development Status
What toxicological data is available?
(use Ctrl for multiple selections)
Is the drug protected by any existing patents?
If yes, What kind of patents exist?
Composition of matter
Use Only
What regions (or countries) are covered by the patents?
North America
Europe
Japan
When will the patents expire?
Are there additional patents either applied for or pending?
Indicate which regions (or countries) are available for licensing:
North America
Europe
Japan
Please give a brief, non-confidential description of the opportunity:
 
Copyright © 2003 Cougar Biotechnology Inc. All rights reserved